Healthcare & Life Sciences
Atrogi
Swedenatrogi.com/
Atrogi is a Healthcare & Life Sciences startup based in Sweden, most recent round Series A, 1 tracked investor.
Activeseries-a
series-a
Stage
1
Investors
About Atrogi
Based in Sweden, Atrogi is a startup. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Atrogi is a clinical-stage biotechnology company developing first-in-class, once-daily oral small-molecule therapies targeting the beta-2 adrenergic receptor for metabolic disorders including type 2 diabetes, obesity, and muscle-wasting. Its lead candidate ATR-258 has completed Phase I and is ready for Phase II clinical trials.
Explore Atrogi's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.